John Demaree

2019

In 2019, John Demaree earned a total compensation of $1.3M as Chief Commercial Officer at G1 Therapeutics, a 82% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$60,000
Option Awards$832,040
Salary$375,000
Other$65,147
Total$1,332,188

Demaree received $832K in option awards, accounting for 62% of the total pay in 2019.

Demaree also received $60K in non-equity incentive plan, $375K in salary and $65.1K in other compensation.

Rankings

In 2019, John Demaree's compensation ranked 7,920th out of 13,971 executives tracked by ExecPay. In other words, Demaree earned more than 43.3% of executives.

ClassificationRankingPercentile
All
7,920
out of 13,971
43rd
Division
Manufacturing
3,115
out of 5,698
45th
Major group
Chemicals And Allied Products
1,178
out of 2,197
46th
Industry group
Drugs
1,006
out of 1,883
47th
Industry
Pharmaceutical Preparations
747
out of 1,395
47th

Pay ratio

John Demaree's Pay$1,332,188
Median Employee's Pay$213,060
Pay Ratio

6

to 1

In 2019, the annual total compensation of John Demaree was $1,332,188.

The annual total compensation of the median employee at G1 Therapeutics was $213,060.

The ratio of John Demaree's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 24, 2020.

Demaree's colleagues

We found five more compensation records of executives who worked with John Demaree at G1 Therapeutics in 2019.

2019

Mark Avagliano

G1 Therapeutics

Chief Business Officer

2019

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2019

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2019

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

2019

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

News

In-depth

You may also like